返回 Agenda
Session 11: Grand Q&A Panel
Session Chair(s)
René Thürmer
Deputy Head of the Unit Pharmaceutical Biotechnology BfArM, Federal Institute for Drugs and Medical Devices, Germany
This session will allow open discussion between the audience and an esteemed panel of experts to ask any remaining questions. Please note: due to the high volume of questions, not all will be answered live at the conference
Speaker(s)
Speaker
Hobart Rogers, PharmD, PhD
Pharmacologist, CDER, FDA, United States
Speaker
Andrew Slugg, MBA, MS
Senior Vice President, Global Head of Regulatory Sciences, Alnylam Pharmaceuticals, United States
Speaker
Jennifer Sisler, PhD
Director, Eli Lilly and Company, United States
Speaker
Xuan Chi, DrMed, DRSc
Supervisory Pharmacologist, CDER, FDA, United States
Speaker
Lubomir Nechev, PhD
Chief CMC Officer, Alnylam Pharmaceuticals, United States